Codexis, Inc. ( CDXS) - Key Metrics
CDXS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.16 | -$0.13 | -$0.11 | -$0.12 |
| 2026Q1 | $0.17 | -$0.10 | -$0.14 | -$0.15 |
| 2025Q4 | $0.43 | $0.11 | $0.22 | $0.22 |
| 2025Q3 | $0.10 | -$0.22 | -$0.09 | -$0.09 |
| 2025Q2 | $0.18 | -$0.16 | -$0.21 | -$0.24 |
CDXS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.35 |
| 2026Q1 | 0% | -4.25 |
| 2025Q4 | 0% | 3.70 |
| 2025Q3 | 0% | -2.77 |
| 2025Q2 | 0% | -3.81 |
CDXS
Price: $1.56
52 week price:
Earnings Per Share: -0.35 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 517700
Ebitda: -9.8 millionMarket Capitalization: 159.2 million